NEW YORK, June 18, 2025 /PRNewswire/ -- Hoth Therapeutics, Inc. (NASDAQ: HOTH), a clinical-stage biopharmaceutical company focused on breakthrough therapies, today announced that it has regained full ...
Hoth Therapeutics (NASDAQ:HOTH) shares rose by a staggering 215% today following significant breakthrough in cancer treatment. Their Phase 2a clinical trial of Hoth's topical gel HT-001 has shown 100% ...
The following post was written and/or published as a collaboration between Benzinga’s in-house sponsored content team and a financial partner of Benzinga. Hoth Therapeutics HOTH is a clinical-stage ...
NEW YORK, April 5, 2021 /PRNewswire/ -- Hoth Therapeutics, Inc. (Nasdaq: HOTH), a patient-focused clinical-stage biopharmaceutical company, today announced that the Brazilian Patent Office has issued ...
Patients will be able to enroll in trial at any time and regardless of failure from other therapeutics This is a randomized, double-blind, placebo-controlled, multi-center Phase 2a dose-ranging study ...
Hoth Therapeutics Inc (NASDAQ:HOTH) shares are soaring Tuesday after the company highlighted proof-of-concept data generated using an Alzheimer's disease mouse model, supporting the therapeutic ...
There isn't a more iconic battle in all of Star Wars than the fight for the planet Hoth in Episode V: The Empire Strikes Back. You could try to argue for other battles throughout the film franchise — ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results